FDA Official Calls OTC Monograph Reform an Agency Priority

Drug Industry Daily
A A
OTC monograph reform “remains a top priority” for the FDA, Lauren Silvis, chief of staff at the FDA’s Office of the Commissioner, said at a Consumer Healthcare Products Association meeting in Rockville, Maryland on Tuesday.

To View This Article:

Login

Subscribe To Drug Industry Daily